American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 270-277 , August 2005

Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis

Received 18 January 2005 ,Accepted 2 May 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2005.05.010 on June 21, 2005.

PII: S0272-6386(05)00623-2

doi: 10.1053/j.ajkd.2005.05.010

American Journal of Kidney Diseases
Volume 46, Issue 2 , Pages 270-277 , August 2005

Article Tools

* Image Usage & Resolution